The extraction and quantification of amyloid-β (Aβ) peptides in brain tissue commonly uses formic acid (FA) to disaggregate Aβ fibrils. However, it is not clear whether FA can disaggregate post-translationally modified Aβ peptides, or whether it induces artifact by covalent modification during disaggregation. Of particular interest are Aβ peptides that have been covalently modified by 4-hydroxy-2-nonenal (HNE), an oxidative lipid degradation product produced in the vicinity of amyloid plaques that dramatically accelerates the aggregation of Aβ peptides.
Objective:
Test the ability of FA to disaggregate Aβ peptides modified by HNE and to induce covalent artifacts.
Methods:
Quantitative liquid-chromatography-tandem-mass spectrometry of monomeric Aβ peptides and identify covalently modified forms.
Results:
FA disaggregated ordinary Aβ fibrils but also induced the time-dependent formylation of at least 2 residue side chains in Aβ peptides, as well as oxidation of its methionine side chain. FA was unable to disaggregate Aβ peptides that had been covalently modified by HNE.
Conclusion:
The inability of FA to disaggregate Aβ peptides modified by HNE prevents FA-based approaches from quantifying a pool of HNE-modified Aβ peptides in brain tissue that may have pathological significance.
AxelsenPH, KomatsuH, MurrayIVJ (2011) Oxidative stress and cell membranes in the pathogenesis of Alzheimer’s disease. Physiology (Bethesda)26, 54–69.
2.
SchneiderC, TallmanKA, PorterNA, BrashAR (2001) Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9-and 13- hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem276, 20831–20838.
3.
LovellMA, EhmannWD, MattsonMP, MarkesberyWR (1997) Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer’s disease. Neurobiol Aging18, 457–461.
4.
MarkesberyWR, LovellMA (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer’s disease. Neurobiol Aging19, 33–36.
5.
McGrathLT, McGleenonBM, BrennanS, McCollD, McIlroyS, PassmoreAP (2001) Increased oxidative stress in Alzheimer’s disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM94, 485–490.
6.
SayreLM, ZelaskoDA, HarrisPLR, PerryG, SalomonRG, SmithMA (1997) 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J Neurochem68, 2092–2097.
7.
UchidaK, StadtmanER (1992) Modification of histidine-residues in proteins by reaction with 4-hydroxynonenal. Proc Natl Acad Sci U S A89, 4544–4548.
8.
FukudaM, KanouF, ShimadaN, SawabeM, SaitoY, MurayamaS, HashimotoM, MaruyamaN, IshigamiA (2009) Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer’s disease. Biomed Res30, 227–233.
9.
MurrayIVJ, LiuL, KomatsuH, UryuK, XiaoG, LawsonJA, AxelsenPH (2007) Membrane mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins. J Biol Chem282, 9335–9345.
10.
KoppakaV, PaulC, MurrayIVJ, AxelsenPH (2003) Early synergy between Ab42 and oxidatively damaged membranes in promoting amyloid fibril formation by Ab40. J Biol Chem278, 36277–36284.
11.
MurrayIVJ, SindoniME, AxelsenPH (2005) Promotion of oxidative lipid membrane damage by amyloid beta proteins. Biochem44, 12606–12613.
12.
KomatsuH, LiuL, MurrayIVJ, AxelsenPH (2007) A mechanistic link between oxidative stress and membrane mediated amyloidogenesis revealed by infrared spectroscopy. Biochim Biophys Acta1768, 1913–1922.
13.
LiuL, KomatsuH, MurrayIVJ, AxelsenPH (2008) Promotion of amyloid beta protein misfolding and fibrillogenesis by a lipid oxidation product. J Mol Biol377, 1236–1250.
14.
SmithMA, HiraiK, HsiaoK, PappollaMA, HarrisPLR, SiedlakSL, TabatonM, PerryG (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem70, 2212–2215.
15.
EllisG, FangE, MaheshwariM, RoltschE, HolcombL, ZimmerD, MartinezD, MurrayIVJ (2010) Lipid oxidation and modification of Amyloid-beta (A beta)and. J Alzheimers Dis22, 593–607.
16.
PapaioannouN, TootenPCJ, van EderenAM, BohlJRE, RofinaJ, TsangarisT, GruysE (2001) Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid8, 11–21.
17.
RofinaJE, SinghK, Skoumalova-VeselaA, van EderenAM, van AstenAJ, WilhelmJ, GruysE (2004) Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine. Amyloid11, 90–100.
18.
AndoY, BrannstromT, UchidaK, NyhlinN, NasmanB, SuhrO, YamashitaT, OlssonT, El SalhyM, UchinoM, AndoM (1998) Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci156, 172–176.
19.
GhanbariHA, GhanbariK, HarrisPLR, JonesPK, KubatZ, CastellaniRJ, WolozinBL, SmithMA, PerryG (2004) Oxidative damage in cultured human olfactory neurons from Alzheimer’s disease patients. Aging Cell3, 41–44.
HayashiT, ShishidoN, NakayamaK, NunomuraA, SmithMA, PerryG, NakamuraM (2007) Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Rad Biol Med43, 1552–1559.
22.
EskiciG, AxelsenPH (2012) Copper and oxidative stress in the pathogenesis of Alzheimer’s disease. Biochem51, 6289–6311.
23.
JarrettJT, BergerEP, LansburyPT (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer’s disease. Biochem32, 4693–4697.
24.
EsterbauerH, SchaurRJ, ZollnerH (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med11, 81–128.
25.
BolgarMS, GaskellSJ (1996) Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Anal Chem68, 2325–2330.
26.
LiptonSH, BodwellCE (1976) Specific oxidation of methionine to methionine sulfoxide by dimethyl sulfoxide. J Agric Food Chem24, 26–31.
27.
SchechterI, BergerA (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun27, 157–162.
28.
GrassoG, AxelsenPH (2017) Effects of covalentmodification by 4-hydroxy-2-nonenal on the noncovalent oligomerization of ubiquitin. J Mass Spec52, 36–42.
29.
SayreLM, LinD, YuanQ, ZhuXC, TangXX (2006) Protein adducts generated from products of lipid oxidation: Focus on HNE and ONE. Drug Metab Rev38, 651–675.
30.
KoppakaV, AxelsenPH (2000) Accelerated accumulation of amyloid beta proteins on oxidatively damaged lipid membranes. Biochemistry39, 10011–10016.
31.
KomatsuH, Feingold-LinkE, SharpKA, RastogiT, AxelsenPH (2010) Intrinsic linear heterogeneity of amyloid beta protein fibrils revealed by higher resolution mass-per-length determinations. J Biol Chem285, 41843–41851.
32.
GrassoG, KomatsuH, AxelsenPH (2017) Covalent modifications of the amyloid beta peptide by hydroxynonenal: Effects on metal ion binding by monomers and insights into the fibril topology. J Inorg Biochem174, 130–136.
33.
OakleyH, ColeSL, LoganS, MausE, ShaoP, CraftJ, Guillozet-BongaartsA, OhnoM, DisterhoftJ, Van EldikLJ, BerryR, VassarR (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J Neurosci26, 10129–10140.
